Glaucoma Clinical Trial
Official title:
Family Studies of Ocular Traits
This study will examine blood specimens from patients with various eye disorders who
previously participated in the Beaver Dam Eye Study to try to identify genes responsible for
these disorders. The Beaver Dam study was designed to determine the incidence and causes of
age-related eye conditions, including cataract (changes in the lens of the eye that can
impair vision); retinopathy (diseases of the retina - the thin layer of tissue that lines the
back of the eye); age-related maculopathy (degeneration or atrophy of the macula - the center
part of the retina responsible for fine vision); and impaired vision. Findings from this
study and others have shown that age-related eye disorders often run in families, indicating
a genetic component in their development.
All participants in the Beaver Dam study who had family members in the study may be included
in the current NHGRI study. The Beaver Dam study included residents of the township of Beaver
Dam, Wisconsin, who were between 45 and 84 years of age at enrollment. Participants had
thorough eye examinations and blood samples drawn at baseline and 5 and 10 years after the
baseline evaluation. Fifteen-year follow-ups will start in 2003.
This study will analyze data and blood samples previously collected from Beaver Dam study
participants to identify genes related to numerous age-related visual traits. No new
participants will be recruited.
The Beaver Dam Eye Study was designed to determine the long-term incidence and causes of
cataract, age-related maculopathy (ARM), retinopathy, and impaired vision. Age-related
macular degeneration and cataract are leading causes of loss of vision in the United States.
In Beaver Dam, preliminary analyses indicate that in those people who were 75+ years of age
at the baseline examination, 72% developed nuclear cataract, 39% developed cortical cataract,
22% developed posterior subcapsular cataract (PSC); 37% developed early ARM (large soft
indistinct drusen, retinal pigment epithelial (RPE) depigmentation, and increased retinal
pigment); 10% developed signs of late ARM (exudative macular degeneration and geographic
atrophy); 37% developed some impairment of vision; and 6% developed severely impaired vision
by the 10-year follow-up. Thus, these are common problems in older persons. Because people 75
years of age and older are the most rapidly growing segment of the population with an
estimated increase of over 60% in the next 25 years, these problems pose a societal burden
due to the large number of older persons they will affect. Additionally, we have observed
substantial familial aggregation for several of these traits: ARM, nuclear cataract, cortical
cataract and ocular refraction. The primary goal of this proposal is to perform linkage
analysis on data collected as part of the Beaver Dam eye study. NHGRI investigators will be
involved in the analysis of coded data only. Dr. Bailey-Wilson may provide financial support
to help cover the cost of DNA extraction from her budgets but NO samples will be sent to
NHGRI. All NHGRI effort on this study will be funded through Dr. Bailey-Wilson s intramural
budget.
In addition to the data from the Beaver Dam Eye study, we will also analyze previously
existing data on glaucoma, intraocular pressure and cup-disc ratio from the Framingham Eye
Study (FES) which is a substudy of the well known cohort study called the Framingham Heart
Study (FHS). We will perform both linkage and association analysis of these data for
comparison to the results found in the BDES data.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A |